|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kunkler IH, Williams LJ, Jack WJL, Cameron
DA and Dixon JM: Breast-conserving surgery with or without
irradiation in early breast cancer. N Engl J Med. 388:585–594.
2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wehrwein EA, Orer HS and Barman SM:
Overview of the anatomy, physiology, and pharmacology of the
autonomic nervous system. Compr Physiol. 6:1239–1278.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hu J, Chen W, Shen L, Chen Z and Huang J:
Crosstalk between the peripheral nervous system and breast cancer
influences tumor progression. Biochim Biophys Acta Rev Cancer.
1877(188828)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cui Q, Jiang D, Zhang Y and Chen C: The
tumor-nerve circuit in breast cancer. Cancer Metastasis Rev.
42:543–574. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Faulkner S, Jobling P, March B, Jiang CC
and Hondermarck H: Tumor neurobiology and the war of nerves in
cancer. Cancer Discov. 9:702–710. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Silverman DA, Martinez VK, Dougherty PM,
Myers JN, Calin GA and Amit M: Cancer-associated neurogenesis and
nerve-cancer cross-talk. Cancer Res. 81:1431–1440. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Monje M, Borniger JC, D'silva NJ, Deneen
B, Dirks PB, Fattahi F, Frenette PS, Garzia L, Gutmann DH, Hanahan
D, et al: Roadmap for the emerging field of cancer neuroscience.
Cell. 181:219–222. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mancusi R and Monje M: The neuroscience of
cancer. Nature. 618:467–479. 2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yaman I, Agac Cobanoglu D, Xie T, Ye Y and
Amit M: Advances in understanding cancer-associated neurogenesis
and its implications on the neuroimmune axis in cancer. Pharmacol
Ther. 239(108199)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shi DD, Guo JA, Hoffman HI, Su J,
Mino-Kenudson M, Barth JL, Schenkel JM, Loeffler JS, Shih HA, Hong
TS, et al: Therapeutic avenues for cancer neuroscience:
Translational frontiers and clinical opportunities. Lancet Oncol.
23:e62–e74. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li RQ, Zhao XH, Zhu Q, Liu T, Hondermarck
H, Thorne RF, Zhang XD and Gao JN: Exploring neurotransmitters and
their receptors for breast cancer prevention and treatment.
Theranostics. 13:1109–1129. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Huang Y, Xiang B, Manyande A, Xiang H and
Xiong J: Neurogenesis manifestations of solid tumor and tracer
imaging studies: A narrative review. Am J Cancer Res. 13:713–726.
2023.PubMed/NCBI
|
|
14
|
Cole SW, Nagaraja AS, Lutgendorf SK, Green
PA and Sood AK: Sympathetic nervous system regulation of the tumour
microenvironment. Nat Rev Cancer. 15:563–572. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Sarhadi NS, Shaw-Dunn J and Soutar DS:
Nerve supply of the breast with special reference to the nipple and
areola: Sir Astley Cooper revisited. Clin Anat. 10:283–288.
1997.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bonaz B: Anti-inflammatory effects of
vagal nerve stimulation with a special attention to intestinal
barrier dysfunction. Neurogastroenterol Motil.
34(e14456)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kox M, Vaneker M, van der Hoeven JG,
Scheffer GJ, Hoedemaekers CW and Pickkers P: Effects of vagus nerve
stimulation and vagotomy on systemic and pulmonary inflammation in
a two-hit model in rats. PLoS One. 7(e34431)2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pundavela J, Roselli S, Faulkner S, Attia
J, Scott RJ, Thorne RF, Forbes JF, Bradshaw RA, Walker MM, Jobling
P and Hondermarck H: Nerve fibers infiltrate the tumor
microenvironment and are associated with nerve growth factor
production and lymph node invasion in breast cancer. Mol Oncol.
9:1626–1635. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Campbell JP, Karolak MR, Ma Y, Perrien DS,
Masood-Campbell SK, Penner NL, Munoz SA, Zijlstra A, Yang X,
Sterling JA and Elefteriou F: Stimulation of host bone marrow
stromal cells by sympathetic nerves promotes breast cancer bone
metastasis in mice. PLoS Biol. 10(e1001363)2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sloan EK, Priceman SJ, Cox BF, Yu S,
Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas
BD, Wu L, et al: The sympathetic nervous system induces a
metastatic switch in primary breast cancer. Cancer Res.
70:7042–7052. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Erin N: Role of sensory neurons,
neuroimmune pathways, and transient receptor potential vanilloid 1
(TRPV1) channels in a murine model of breast cancer metastasis.
Cancer Immunol Immunother. 69:307–314. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Erin N, Akman M, Aliyev E, Tanrıöver G and
Korcum AF: Olvanil activates sensory nerve fibers, increases T cell
response and decreases metastasis of breast carcinoma. Life Sci.
291(120305)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Erin N and Szallasi A: Carcinogenesis and
metastasis: Focus on TRPV1-positive neurons and immune cells.
Biomolecules. 13(983)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chang A, Le CP, Walker AK, Creed SJ, Pon
CK, Albold S, Carroll D, Halls ML, Lane JR, Riedel B, et al:
β2-Adrenoceptors on tumor cells play a critical role in
stress-enhanced metastasis in a mouse model of breast cancer. Brain
Behav Immun. 57:106–115. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Qiao G, Chen M, Bucsek MJ, Repasky EA and
Hylander BL: Adrenergic signaling: A targetable checkpoint limiting
development of the antitumor immune response. Front Immunol.
9(164)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Qin JF, Jin FJ, Li N, Guan HT, Lan L, Ni H
and Wang Y: Adrenergic receptor β2 activation by stress promotes
breast cancer progression through macrophages M2 polarization in
tumor microenvironment. BMB Rep. 48:295–300. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Scott JM, Jones LW, Hornsby WE, Koelwyn
GJ, Khouri MG, Joy AA, Douglas PS and Lakoski SG: Cancer
therapy-induced autonomic dysfunction in early breast cancer:
Implications for aerobic exercise training. Int J Cardiol.
171:e50–e501. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Arab C, Dias DP, Barbosa RT, Carvalho TD,
Valenti VE, Crocetta TB, Ferreira M, Abreu LC and Ferreira C: Heart
rate variability measure in breast cancer patients and survivors: A
systematic review. Psychoneuroendocrinology. 68:57–68.
2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Winkler F, Venkatesh HS, Amit M, Batchelor
T, Demir IE, Deneen B, Gutmann DH, Hervey-Jumper S, Kuner T,
Mabbott D, et al: Cancer neuroscience: State of the field, emerging
directions. Cell. 186:1689–1707. 2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li D, Hu LN, Zheng SM, La T, Wei LY, Zhang
XJ, Zhang ZH, Xing J, Wang L, Li RQ, et al: High nerve density in
breast cancer is associated with poor patient outcome. FASEB
Bioadv. 4:391–401. 2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Szpunar MJ, Belcher EK, Dawes RP and
Madden KS: Sympathetic innervation, norepinephrine content, and
norepinephrine turnover in orthotopic and spontaneous models of
breast cancer. Brain Behav Immun. 53:223–233. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Conceicao F, Sousa DM, Paredes J and
Lamghari M: Sympathetic activity in breast cancer and metastasis:
Partners in crime. Bone Res. 9(9)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jayachandran P, Battaglin F, Strelez C,
Lenz A, Algaze S, Soni S, Lo JH, Yang Y, Millstein J, Zhang W, et
al: Breast cancer and neurotransmitters: Emerging insights on
mechanisms and therapeutic directions. Oncogene. 42:627–637.
2023.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu D, Deng Q, Sun L, Wang T, Yang Z, Chen
H, Guo L, Liu Y, Ma Y, Guo N and Shi M: A Her2-let-7-β2-AR circuit
affects prognosis in patients with Her2-positive breast cancer. BMC
Cancer. 15(832)2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kurozumi S, Kaira K, Matsumoto H, Hirakata
T, Yokobori T, Inoue K, Horiguchi J, Katayama A, Koshi H, Shimizu
A, et al: β2-Adrenergic receptor expression is
associated with biomarkers of tumor immunity and predicts poor
prognosis in estrogen receptor-negative breast cancer. Breast
Cancer Res Treat. 177:603–610. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu Y, Sun J, Wu T, Lu X, Du Y, Duan H, Yu
W, Su D, Lu J and Tian J: Effects of serum from breast cancer
surgery patients receiving perioperative dexmedetomidine on breast
cancer cell malignancy: A prospective randomized controlled trial.
Cancer Med. 8:7603–7612. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chi M, Shi X, Huo X, Wu X, Zhang P and
Wang G: Dexmedetomidine promotes breast cancer cell migration
through Rab11-mediated secretion of exosomal TMPRSS2. Ann Transl
Med. 8(531)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Xia M, Ji NN, Duan ML, Tong JH, Xu JG,
Zhang YM and Wang SH: Dexmedetomidine regulate the malignancy of
breast cancer cells by activating α2-adrenoceptor/ERK signaling
pathway. Eur Rev Med Pharmacol Sci. 20:3500–3506. 2016.PubMed/NCBI
|
|
39
|
Carnet Le Provost K, Kepp O, Kroemer G and
Bezu L: Trial watch: Dexmedetomidine in cancer therapy.
Oncoimmunology,. 2024, 13: 2327143, 2024.
|
|
40
|
Xia M, Tong JH, Zhou ZQ, Duan ML, Xu JG,
Zeng HJ and Wang SH: Tramadol inhibits proliferation, migration and
invasion via α2-adrenoceptor signaling in breast cancer cells. Eur
Rev Med Pharmacol Sci. 20:157–165. 2016.PubMed/NCBI
|
|
41
|
Scully OJ, Bay BH, Yip G and Yu Y: Breast
cancer metastasis. Cancer Genomics Proteomics. 9:311–320.
2012.PubMed/NCBI
|
|
42
|
Barron TI, Connolly RM, Sharp L, Bennett K
and Visvanathan K: Beta blockers and breast cancer mortality: A
population-based study. J Clin Oncol. 29:2635–2644. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Phadke S and Clamon G: Beta blockade as
adjunctive breast cancer therapy: A review. Crit Rev Oncol Hematol.
138:173–177. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang T, Li Y, Lu HL, Meng QW, Cai L and
Chen XS: β-Adrenergic receptors : New target in breast cancer.
Asian Pac J Cancer Prev. 16:8031–8039. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Montoya A, Amaya CN, Belmont A, Diab N,
Trevino R, Villanueva G, Rains S, Sanchez LA, Badri N, Otoukesh S,
et al: Use of non-selective β-blockers is associated with decreased
tumor proliferative indices in early stage breast cancer.
Oncotarget. 8:6446–6460. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Montoya A, Varela-Ramirez A, Dickerson E,
Pasquier E, Torabi A, Aguilera R, Nahleh Z and Bryan B: The beta
adrenergic receptor antagonist propranolol alters mitogenic and
apoptotic signaling in late stage breast cancer. Biomed J.
42:155–165. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhao Y, Wang Q, Zhao X, Meng H and Yu J:
Effect of antihypertensive drugs on breast cancer risk in female
hypertensive patients: Evidence from observational studies. Clin
Exp Hypertens. 40:22–27. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Caparica R, Bruzzone M, Agostinetto E, De
Angelis C, Fêde Â, Ceppi M and de Azambuja E: Β-blockers in
early-stage breast cancer: A systematic review and meta-analysis.
ESMO Open. 6(100066)2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Raimondi S, Botteri E, Munzone E, Cipolla
C, Rotmensz N, DeCensi A and Gandini S: Use of β-blockers,
angiotensin-converting enzyme inhibitors and angiotensin receptor
blockers and breast cancer survival: Systematic review and
meta-analysis. Int J Cancer. 139:212–219. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Strell C, Smith DR, Valachis A, Woldeyesus
H, Wadsten C, Micke P, Fredriksson I and Schiza A: Use of
beta-blockers in patients with ductal carcinoma in situ and risk of
invasive breast cancer recurrence: A Swedish retrospective cohort
study. Breast Cancer Res Treat. 207:293–299. 2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Hiller JG, Cole SW, Crone EM, Byrne DJ,
Shackleford DM, Pang JB, Henderson MA, Nightingale SS, Ho KM, Myles
PS, et al: Preoperative β-Blockade with propranolol reduces
biomarkers of metastasis in breast cancer: A phase II Randomized
trial. Clin Cancer Res. 26:1803–1811. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Cardwell CR, Pottegard A, Vaes E, Garmo H,
Murray LJ, Brown C, Vissers PA, O'Rorke M, Visvanathan K,
Cronin-Fenton D, et al: Propranolol and survival from breast
cancer: A pooled analysis of European breast cancer cohorts. Breast
Cancer Res. 18(119)2016.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Scott OW, TinTin S, Cavadino A and Elwood
JM: Beta-blocker use and breast cancer outcomes: A meta-analysis.
Breast Cancer Res Treat. 206:443–463. 2024.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Li C, Li T, Tang R, Yuan S and Zhang W:
β-Blocker use is not associated with improved clinical outcomes in
women with breast cancer: A meta-analysis. Biosci Rep.
40(BSR20200721)2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Kim HY, Jung YJ, Lee SH, Jung HJ and Pak
K: Is beta-blocker use beneficial in breast cancer? A
meta-analysis. Oncology. 92:264–268. 2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Løfling LL, Støer NC, Sloan EK, Chang A,
Gandini S, Ursin G and Botteri E: β-blockers and breast cancer
survival by molecular subtypes: A population-based cohort study and
meta-analysis. Br J Cancer. 127:1086–1096. 2022.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Erin N, Akdas Barkan G, Harms JF and
Clawson GA: Vagotomy enhances experimental metastases of 4THMpc
breast cancer cells and alters substance P. level. Regul Pept.
151:35–42. 2008.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Erin N, Barkan GA and Clawson GA: Vagus
nerve regulates breast cancer metastasis to the adrenal gland.
Anticancer Res. 33:3675–3682. 2013.PubMed/NCBI
|
|
59
|
Han H, Yang C, Zhang Y, Han C and Zhang G:
Vascular endothelial growth factor mediates the sprouted
axonogenesis of breast cancer in rat. Am J Pathol. 191:515–526.
2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Giese-Davis J, Wilhelm FH, Tamagawa R,
Palesh O, Neri E, Taylor CB, Kraemer HC and Spiegel D: Higher vagal
activity as related to survival in patients with advanced breast
cancer: An analysis of autonomic dysregulation. Psychosom Med.
77:346–355. 2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Huang WB, Lai HZ, Long J, Ma Q, Fu X, You
FM and Xiao C: Vagal nerve activity and cancer prognosis: A
systematic review and meta-analysis. BMC Cancer.
25(579)2025.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Kloter E, Barrueto K, Klein SD, Scholkmann
F and Wolf U: Heart rate variability as a prognostic factor for
cancer survival-a systematic review. Front Physiol.
9(623)2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Borovikova LV, Ivanova S, Zhang M, Yang H,
Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW and Tracey
KJ: Vagus nerve stimulation attenuates the systemic inflammatory
response to endotoxin. Nature. 405:458–462. 2000.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Rosas-Ballina M, Olofsson PS, Ochani M,
Valdés-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA,
Andersson U, Chavan S, et al: Acetylcholine-synthesizing T cells
relay neural signals in a vagus nerve circuit. Science. 334:98–101.
2011.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Bonaz B, Picq C, Sinniger V, Mayol JF and
Clarençon D: Vagus nerve stimulation: from epilepsy to the
cholinergic anti-inflammatory pathway. Neurogastroenterol Motil.
25:208–221. 2013.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444.
2008.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Bogeska R, Mikecin AM, Kaschutnig P, Fawaz
M, Büchler-Schäff M, Le D, Ganuza M, Vollmer A, Paffenholz SV,
Asada N, et al: Inflammatory exposure drives long-lived impairment
of hematopoietic stem cell self-renewal activity and accelerated
aging. Cell Stem Cell. 29:1273–1284 e8. 2022.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Wu S, Xie S, Yuan C, Yang Z, Liu S, Zhang
Q, Sun F, Wu J, Zhan S, Zhu S and Zhang S: Inflammatory bowel
disease and long-term risk of cancer: A prospective cohort study
among half a million adults in UK Biobank. Inflamm Bowel Dis.
29:384–395. 2023.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Erin N, Duymus O, Ozturk S and Demir N:
Activation of vagus nerve by semapimod alters substance P. levels
and decreases breast cancer metastasis. Regul Pept. 179:101–108.
2012.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Lai Y, Zhou X, Guo F, Jin X, Meng G, Zhou
L, Chen H, Liu Z, Yu L and Jiang H: Non-invasive transcutaneous
vagus nerve stimulation improves myocardial performance in
doxorubicin-induced cardiotoxicity. Cardiovasc Res. 118:1821–1834.
2022.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Prathumsap N, Ongnok B, Khuanjing T,
Arinno A, Maneechote C, Apaijai N, Chunchai T, Arunsak B, Kerdphoo
S, Janjek S, et al: Vagus nerve stimulation exerts cardioprotection
against doxorubicin-induced cardiotoxicity through inhibition of
programmed cell death pathways. Cell Mol Life Sci.
80(21)2022.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Guo F, Wang Y, Wang J, Liu Z, Lai Y, Zhou
Z, Liu Z, Zhou Y, Xu X, Li Z, et al: Choline protects the heart
from doxorubicin-induced cardiotoxicity through vagal activation
and Nrf2/HO-1 pathway. Oxid Med Cell Longev.
2022(4740931)2022.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Panebianco M, Rigby A and Marson AG: Vagus
nerve stimulation for focal seizures. Cochrane Database Syst Rev.
7(CD002896)2022.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Marwaha S, Palmer E, Suppes T, Cons E,
Young AH and Upthegrove R: Novel and emerging treatments for major
depression. Lancet. 401:141–153. 2023.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Liu YL, Wang SR, Ma JX, Yu LH and Jia GW:
Vagus nerve stimulation is a potential treatment for ischemic
stroke. Neural Regen Res. 18:825–831. 2023.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Johnson RL and Wilson CG: A review of
vagus nerve stimulation as a therapeutic intervention. J Inflamm
Res. 11:203–213. 2018.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Capilupi MJ, Kerath SM and Becker LB:
Vagus nerve stimulation and the cardiovascular system. Cold Spring
Harb Perspect Med. 10(a034173)2020.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Liu L, Lou S, Fu D, Ji P, Xia P, Shuang S,
Dong W, Yuan X, Wang J, Xie K, et al: Neuro-immune interactions:
Exploring the anti-inflammatory role of the vagus nerve. Int
Immunopharmacol. 159(114941)2025.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Santos-De-Araujo AD, Shida-Marinho R and
Pontes-Silva A: Heart rate variability (HRV): Checklist for
observational and experimental studies. Autoimmun Rev.
21(103190)2022.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Gregoire JM, Gilon C, Carlier S and
Bersini H: Autonomic nervous system assessment using heart rate
variability. Acta Cardiol. 78:648–662. 2023.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Arab C, Vanderlei LCM, Da Silva Paiva L,
Fulghum KL, Fristachi CE, Nazario ACP, Elias S, Gebrim LH, Ferreira
Filho C, Gidron Y and Ferreira C: Cardiac autonomic modulation
impairments in advanced breast cancer patients. Clin Res Cardiol.
107:924–936. 2018.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Vigo C, Gatzemeier W, Sala R, Malacarne M,
Santoro A, Pagani M and Lucini D: Evidence of altered autonomic
cardiac regulation in breast cancer survivors. J Cancer Surviv.
9:699–706. 2015.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Wu S, Chen M, Wang J, Shi B and Zhou Y:
Association of short-term heart rate variability with breast tumor
stage. Front Physiol. 12(678428)2021.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Majerova K, Zvarik M, Ricon-Becker I,
Hanalis-Miller T, Mikolaskova I, Bella V, Mravec B and Hunakova L:
Increased sympathetic modulation in breast cancer survivors
determined by measurement of heart rate variability. Sci Rep.
12(14666)2022.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Caro-Morán E, Fernández-Lao C,
Galiano-Castillo N, Cantarero-Villanueva I, Arroyo-Morales M and
Díaz-Rodríguez L: Heart rate variability in breast cancer survivors
after the first year of treatments: A case-controlled study. Biol
Res Nurs. 18:43–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Thornton LM, Andersen BL and Blakely WP:
The pain, depression, and fatigue symptom cluster in advanced
breast cancer: covariation with the hypothalamic-pituitary-adrenal
axis and the sympathetic nervous system. Health Psychol.
29:333–337. 2010.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Childers WK, Hollenbeak CS and Cheriyath
P: β-blockers reduce breast cancer recurrence and breast cancer
death: A meta-analysis. Clin Breast Cancer. 15:426–431.
2015.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Lewinter C, Nielsen TH, Edfors LR, Linde
C, Bland JM, LeWinter M, Cleland JGF, Køber L, Braunschweig F and
Mansson-Broberg A: A systematic review and meta-analysis of
beta-blockers and renin-angiotensin system inhibitors for
preventing left ventricular dysfunction due to anthracyclines or
trastuzumab in patients with breast cancer. Eur Heart J.
43:2562–2569. 2022.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Mravec B: Βeta-blockers and breast
cancer-letter. Cancer Epidemiol Biomarkers Prev.
30(1765)2021.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Shaashua L, Shabat-Simon M, Haldar R,
Matzner P, Zmora O, Shabtai M, Sharon E, Allweis T, Barshack I,
Hayman L, et al: Perioperative COX-2 and β-Adrenergic blockade
improves metastatic biomarkers in breast cancer patients in a
phase-II Randomized trial. Clin Cancer Res. 23:4651–4661.
2017.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Haldar R, Shaashua L, Lavon H, Lyons YA,
Zmora O, Sharon E, Birnbaum Y, Allweis T, Sood AK, Barshack I, et
al: Perioperative inhibition of β-adrenergic and COX2 signaling in
a clinical trial in breast cancer patients improves tumor Ki-67
expression, serum cytokine levels, and PBMCs transcriptome. Brain
Behav Immun. 73:294–309. 2018.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Xie M, Guo F, Song L, Tan W, Han X, Xu S,
Li X, Wang Y, Wang Y, Zhou L, et al: Noninvasive neuromodulation
protects against doxorubicin-induced cardiotoxicity and inhibits
tumor growth. iScience. 27(109163)2024.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Nectow AR and Nestler EJ: Viral tools for
neuroscience. Nat Rev Neurosci. 21:669–681. 2020.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Hui Y, Zheng X, Zhang H, Li F, Yu G, Li J,
Zhang J, Gong X and Guo G: Strategies for targeting neural
circuits: How to manipulate neurons using virus vehicles. Front
Neural Circuits. 16(882366)2022.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Betley JN and Sternson SM:
Adeno-associated viral vectors for mapping, monitoring, and
manipulating neural circuits. Hum Gene Ther. 22:669–677.
2011.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Wen HZ, Xiong SY, Lou YX, Yang SZ, Sun L,
Yi YL, Tang BQ, Shu Q, Wang ZQ, Yan XJ, et al: Social interaction
in mice suppresses breast cancer progression via a corticoamygdala
neural circuit. Neuron. 113:3374–3389.e9. 2025.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Xiong SY, Wen HZ, Dai LM, Lou YX, Wang ZQ,
Yi YL, Yan XJ, Wu YR, Sun W, Chen PH, et al: A brain-tumor neural
circuit controls breast cancer progression in mice. J Clin Invest.
133(e167725)2023.PubMed/NCBI View Article : Google Scholar
|
